SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing liquid biopsies to improve the detection and treatment of cancer, announces that President and CEO Michael Nall is scheduled to present a corporate overview at the Rodman & Renshaw 17th Annual Global Investment Conference on September 9, 2015, at 2:10 p.m. Eastern time (11:10 a.m. Pacific time). The conference is being held at the St. Regis Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.
